GeneOne Life Science, Inc. (KRX:011000)

GeneOne Life Science Statistics

Total Valuation

KRX:011000 has a market cap or net worth of KRW 161.26 billion. The enterprise value is 186.64 billion.

Market Cap	161.26B
Enterprise Value	186.64B

Important Dates

The last earnings date was Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:011000 has 79.83 million shares outstanding. The number of shares has increased by 2.15% in one year.

Current Share Class	n/a
Shares Outstanding	79.83M
Shares Change (YoY)	+2.15%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	10.73%
Owned by Institutions (%)	4.63%
Float	71.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.49
PB Ratio	1.88
P/TBV Ratio	1.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.85
EV / Sales	5.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.64

Financial Position

The company has a current ratio of 0.67, with a Debt / Equity ratio of 0.32.

Current Ratio	0.67
Quick Ratio	0.23
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	-1.40
Interest Coverage	-19.96

Financial Efficiency

Return on equity (ROE) is -49.25% and return on invested capital (ROIC) is -22.29%.

Return on Equity (ROE)	-49.25%
Return on Assets (ROA)	-17.79%
Return on Invested Capital (ROIC)	-22.29%
Return on Capital Employed (ROCE)	-39.55%
Revenue Per Employee	776.52M
Profits Per Employee	-1.06B
Employee Count	46
Asset Turnover	0.24
Inventory Turnover	2.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.48% in the last 52 weeks. The beta is -1.89, so KRX:011000's price volatility has been lower than the market average.

Beta (5Y)	-1.89
52-Week Price Change	-23.48%
50-Day Moving Average	2,144.50
200-Day Moving Average	2,373.62
Relative Strength Index (RSI)	39.68
Average Volume (20 Days)	253,786

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:011000 had revenue of KRW 35.72 billion and -48.54 billion in losses. Loss per share was -611.00.

Revenue	35.72B
Gross Profit	-10.97B
Operating Income	-43.04B
Pretax Income	-48.75B
Net Income	-48.54B
EBITDA	-25.08B
EBIT	-43.04B
Loss Per Share	-611.00

Balance Sheet

The company has 1.75 billion in cash and 27.13 billion in debt, giving a net cash position of -25.38 billion or -317.92 per share.

Cash & Cash Equivalents	1.75B
Total Debt	27.13B
Net Cash	-25.38B
Net Cash Per Share	-317.92
Equity (Book Value)	85.61B
Book Value Per Share	1,073.13
Working Capital	-13.87B

Cash Flow

In the last 12 months, operating cash flow was -16.06 billion and capital expenditures -3.30 billion, giving a free cash flow of -19.36 billion.

Operating Cash Flow	-16.06B
Capital Expenditures	-3.30B
Free Cash Flow	-19.36B
FCF Per Share	-242.46

Margins

Gross margin is -30.70%, with operating and profit margins of -120.49% and -135.88%.

Gross Margin	-30.70%
Operating Margin	-120.49%
Pretax Margin	-136.49%
Profit Margin	-135.88%
EBITDA Margin	-70.21%
EBIT Margin	-120.49%
FCF Margin	n/a

Dividends & Yields

KRX:011000 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.15%
Shareholder Yield	-2.15%
Earnings Yield	-30.10%
FCF Yield	-12.00%

Stock Splits

The last stock split was on December 3, 2021. It was a forward split with a ratio of 1.5.

Last Split Date	Dec 3, 2021
Split Type	Forward
Split Ratio	1.5

Scores

KRX:011000 has an Altman Z-Score of -1.47. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.47
Piotroski F-Score	n/a